Eterna Therapeutics
Unverified Launch date
Employees
Market cap
$9.6m
Net debt
($42.3m)
Enterprise valuation
$52m (Public information from Jun 2024)
Share price
$1.76 ERNA
Cambridge Massachusetts (HQ)
Deals in current and previous year:
| USD | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | (29040 %) |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | - | (31865 %) |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | - | - | 8706 % |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| investor investor | $0.0 | round | |
* | N/A | $9.2m | Post IPO Convertible |
| Total Funding | 000k | ||
Recent News about Eterna Therapeutics
EditInvestments by Eterna Therapeutics
Edit
ACQUISITION by Eterna Therapeutics May 2023